<DOC>
	<DOCNO>NCT01291030</DOCNO>
	<brief_summary>Hypomagnesemia common renal transplant recipient mainly enhance renal magnesium wasting , cause immunosuppressive drug ( calcineurin inhibitor ) . Glucose metabolism disorder , include insulin resistance decrease insulin secretion , also prevalent post-transplantation often precede development diabetes . As magnesium supplementation demonstrate increase insulin sensitivity diabetic non-diabetic patient , potential therapeutic supplementation ( post-transplantation ) deserve examination . The hypothesis magnesium supplementation renal transplant recipient exert beneficial effect insulin resistance and/or secretion .</brief_summary>
	<brief_title>The Impact Magnesium Supplementation Insulin Resistance Secretion Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Renal transplantation recipient &gt; 18 year age 4 month posttransplantation Hypomagnesemia &lt; 1,8 milligram/deciliter 2 consecutive blood sample ( laboratory reference interval 1,7 2,55 milligram/deciliter ) least 1 month apart . Preexisting diabetes mellitus define intake antidiabetic drug time inclusion Biopsy prove acute rejection consecutive treatment corticosteroid boluses less 2 month inclusion Serum creatinine &gt; 3 milligram/deciliter Active infection ( C reactive protein &gt; 3 milligram/deciliter ) Severe hypomagnesemia ( &lt; 1,2 milligram/deciliter ) Hypokalemia ( &lt; 3,5 milliequivalent/liter ) Severe hypocalcemia ( &lt; 6,5 milligram/deciliter ) Intake digoxin Intake magnesium supplementation 2 week randomization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>